Particle-induced endophthalmitis: Possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 3, 2013, Pages 1758-1766

  Otsuka, Hiroki ^a   Kawano, Hiroki ^a   Sonoda, Shozo ^a   Nakamura, Makoto ^b   Sakamoto, Taiji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTODOXONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; ENDOPHTHALMITIS; GRANULOCYTE; HUMAN; HUMAN CELL; INCIDENCE; INFLAMMATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; VISUAL ACUITY;

AQUEOUS HUMOR; CELLS, CULTURED; CYTOKINES; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; EPITHELIAL CELLS; GLUCOCORTICOIDS; GRANULOCYTES; GRANULOMA, FOREIGN-BODY; HUMANS; INTRAVITREAL INJECTIONS; LENS, CRYSTALLINE; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; RETINAL VEIN OCCLUSION; TRIAMCINOLONE ACETONIDE;

EID: 84875449436     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11247     Document Type: Review

References (37)

1. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.
2. Sakamoto T, Ishibashi T, Ogura Y, et al. Japanese Retina and Vitreous Society Triamcinolone Survey Group. Survey of triamcinolone-related non-infectious endophthalmitis [in Japanese]. Nihon Ganka Gakkai Zasshi. 2011;115:523-528.
3. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 2003;121:1279-1282.
4. Yoon SJ, Rhee DY, Marx JL, et al. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone. Am J Ophthalmol. 2009;147:1031-1036.
5. Wang LC, Yang CM. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide. Ocul Immunol Inflamm. 2005;13:295-300.
6. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol. 2003;87:972-974.
7. Taban M, Singh RP, Chung JY, Lowder CY, Perez VL, Kaiser PK. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis. Am J Ophthalmol. 2007; 144:50-54.
8. Maia M, Farah ME, Belfort RN, et al. Effects of intravitreal triamcinolone acetonide injection with and without preservative. Br J Ophthalmol. 2007;91:1122-1124.
9. Lorenzo Carrero J, González Barcia M, Pérez Flores I. Sterile endophthalmitis after benzyl alcohol filtered triamcinolone acetonide injection. Arch Ophthalmol. 2008;126:142-143.
10. Stepien KE, Eaton AM, Jaffe GJ, Davis JL, Raja J, Feuer W. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006. Retina. 2009;29: 207-213.
11. Jonas JB, Kreissig I, Spandau UH, Harder B. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. Am J Ophthalmol. 2006;141:579-580.
12. Jonisch J, Lai JC, Deramo VA, Flug AJ, Fastenberg DM. Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide. Br J Ophthalmol. 2008;92:1051-1054.
13. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infections and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003;23:686-691.
14. Iwaki M, Ito S, Morioka M, et al. Mechanical stretch enhances IL-8 production in pulmonary microvascular endothelial cells. Biochem Biophys Res Commun. 2009;389:531-536.
15. Sheikh S, Rainger GE, Gale Z, Rahman M, Nash GB. Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-alpha: a basis for local variations in vascular sensitivity to inflammation. Blood. 2003;102:2828-2834.
16. Tsuda A, Stringer BK, Mijailovich SM, Rogers RA, Hamada K, Gray ML. Alveolar cell stretching in the presence of fibrous particles induces interleukin-8 responses. Am J Respir Cell Mol Biol. 1999;21:455-462.
17. Driscoll KE, Carter JM, Hassenbein DG, Howard B. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect. 1997;105(suppl 5):1159-1164.
18. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237-241.
19. Arimura N, Otsuka H, Yamakiri K, et al. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. Ophthalmology. 2009;116:921-926.
20. Shimura M, Nakazawa T, Yasuda K, et al. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol. 2008;145:854-861.
21. Finger PT, Papp C, Latkany P, Kurli M, Iacob CE. Anterior chamber paracentesis cytology (cytospin technique) for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2006;90: 690-692.
22. Uchino E, Sonoda S, Kinukawa N, Sakamoto T. Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine. 2006;33: 36-40.
23. Otsuka H, Arimura N, Sonoda S, et al. Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment. Am J Pathol. 2010;177:2268-2277.
24. Spitzer MS, Mlynczak T, Schultheiss M, et al. Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibility. Retina. 2011;2050-2057.
25. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 1985; 230:1375-1378.
26. Georgopoulos M, Polak K, Prager F, Prünte C, Schmidt-Erfurth U. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol. 2009;93:457-462.
27. Takase H, Futagami Y, Yoshida T, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci. 2006;47: 1557-1561.
28. Curnow SJ, Falciani F, Durrani OM, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci. 2005; 46:4251-4259.
29. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine. 1989;1:2-13.
30. Szurman P, Sierra A, Kaczmarek R, et al. Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res. 2007;85:44-53.
31. Lüke M, Januschowski K, Beutel J, et al. The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina. Exp Eye Res. 2008;87:22-29.
32. Terui Y, Ikeda M, Tomizuka H, et al. Activated endothelial cells induce apoptosis in leukemic cells by endothelial interleukin-8. Blood. 1998;92:2672-2680.
33. Kadl A, Bochkov VN, Huber J, Leitinger N. Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid Redox Signal. 2004;6:311-320.
34. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69:513-521.
35. Glowacka E, Lewkowicz P, Rotsztejn H, Zalewska A. IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils-fibroblasts interaction in psoriasis. Adv Med Sci. 2010;55:254-260.
36. Ferrick MR, Thurau SR, Oppenheim MH, et al. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci. 1991;32:1534-1539.
37. Moshfeghi AA, Nugent AK, Nomoto H, et al. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina. 2009;29:689-698.